As of Jul 23
| -1.68 / -1.03%|
The 13 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 222.00, with a high estimate of 250.00 and a low estimate of 198.00. The median estimate represents a +37.52% increase from the last price of 161.43.
The current consensus among 13 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.